Safety and efficacy of vitamin B(2) (riboflavin) produced by Ashbya gossypii DSM 23096 for all animal species based on a dossier submitted by BASF SE

The European Commission asked EFSA for an opinion on the safety for the target animals, consumer, user and the environment and on the efficacy of a riboflavin‐based additive (minimum 80%) produced by a genetically modified strain of Ashbya gossypii (DSM 23096). It is intended to be used in feed for...

Descripción completa

Detalles Bibliográficos
Autores principales: Rychen, Guido, Aquilina, Gabriele, Azimonti, Giovanna, Bampidis, Vasileios, Bastos, Maria de Lourdes, Bories, Georges, Chesson, Andrew, Cocconcelli, Pier Sandro, Flachowsky, Gerhard, Gropp, Jürgen, Kolar, Boris, Kouba, Maryline, López‐Alonso, Marta, López Puente, Secundino, Mantovani, Alberto, Mayo, Baltasar, Ramos, Fernando, Saarela, Maria, Villa, Roberto Edoardo, Wester, Pieter, Costa, Lucio, Dierick, Noël, Glandorf, Boet, Herman, Lieve, Kärenlampi, Sirpa, Leng, Lubomir, Tebbe, Christoph, Aguilera, Jaime, Manini, Paola, Tarrés‐Call, Jordi, Wallace, Robert John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Scientific Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009745/
https://www.ncbi.nlm.nih.gov/pubmed/32625973
http://dx.doi.org/10.2903/j.efsa.2018.5337

Ejemplares similares

Ejemplares similares